SCHEMBL6996053

SCHEMBL6996053

CC(CCCc1ccccc1)NN

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.51
MAOA P21397 3/20 0.46
PTGS1 P23219 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.45
KDM1A O60341 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
CYP2C8 P10632 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
IDO1 P14902 1/20 0.45
TSHR P16473 1/20 0.45
NFKB1 P19838 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10396064 0.88 ALDH1A1 (0.54) SIGMAR1MAOAPTGS1MEN1KMT2A
SCHEMBL15907606 0.82 SIGMAR1 (0.59) SIGMAR1L3MBTL1MEN1KMT2A
SCHEMBL6998336 0.79 AOC3 (0.46) SIGMAR1KMT2ALMNACYP2D6CYP2C9
SCHEMBL3712834 0.78 SLC6A2 (0.56) SIGMAR1MAOASLC6A2MAOBAOC3
SCHEMBL12986367 0.78 SMN1; SMN2 (0.56) MEN1KMT2ANPC1ALDH1A1CYP1A2
SCHEMBL108633 0.77 LMNA (0.54) SIGMAR1L3MBTL1LMNAAOC3
SCHEMBL19090603 0.77 SIGMAR1 (0.50) SIGMAR1MAOAL3MBTL1MEN1KMT2A
SCHEMBL11132051 0.77 SIGMAR1 (0.64) SIGMAR1LMNACYP1A2CYP3A4HTR1A
Bromide SCHEMBL14833545 0.76 SLC6A2 (0.54) SIGMAR1MAOASLC6A2MAOBAOC3
Pheniprazine SCHEMBL163709 0.75 SIGMAR1 (0.65) SIGMAR1MAOAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1151155-C 1, 5-dihydro-pyrazolo [3, 4-D ] -pyrimidone derivatives 2004-05-26 CN disclosed
EP-0973774-B1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2003-01-22 EP disclosed
US-6174884-B1 CARDIOVASCULAR DISORDERS; CEREBROVASCULAR DISEASES; VASCULAR SYSTEM DISORDERS, ESPECIALLY THE PERIPHERAL BLOOD VESSELS; UROGENITAL DISORDERS; HYPOTENSIVE AGENTS; ANTIARRYTHMIA AND -ISCHEMIC AGENTS; PHOSPHODIESTERASE ACTIVITY BAYER AKTIENGESELLSCHAFT (DE) 2001-01-16 US disclosed
CN-1255133-A 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives BAYER AG (DE) 2000-05-31 CN disclosed
EP-0973774-A1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2000-01-26 EP disclosed
WO-1998040384-A1 1,5-DIHYDRO-PYRAZOLO[3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1998-09-17 WO disclosed